HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ho Sub Lee Selected Research

si-wu-tang

1/2018Ligustilide attenuates vascular inflammation and activates Nrf2/HO-1 induction and, NO synthesis in HUVECs.
1/2016Vascular Protective Role of Samul-Tang in HUVECs: Involvement of Nrf2/HO-1 and NO.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ho Sub Lee Research Topics

Disease

33Inflammation (Inflammations)
12/2021 - 07/2005
17Atherosclerosis
01/2021 - 07/2005
12Hypertension (High Blood Pressure)
01/2022 - 04/2002
8Fibrosis (Cirrhosis)
03/2022 - 01/2014
7Insulin Resistance
03/2019 - 11/2004
7Edema (Dropsy)
05/2017 - 01/2012
6Acute Kidney Injury (Acute Renal Failure)
01/2021 - 03/2004
5Hyperlipidemias (Hyperlipidemia)
01/2021 - 01/2011
5Diabetic Nephropathies (Diabetic Nephropathy)
09/2020 - 01/2014
4Vascular Diseases (Vascular Disease)
01/2021 - 06/2010
4Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2016 - 01/2007
4Nephrosis
02/2015 - 05/2012
4Diabetic Angiopathies (Diabetic Angiopathy)
11/2014 - 12/2010
4Ischemia
01/2011 - 08/2004
3Nephrotic Syndrome (Syndrome, Nephrotic)
03/2022 - 01/2014
3Renovascular Hypertension (Goldblatt Syndrome)
10/2020 - 01/2002
3Obesity
03/2016 - 12/2007
3Dyslipidemias (Dyslipidemia)
03/2016 - 01/2014
2Hypertrophy
12/2020 - 01/2018
2Heart Failure
12/2020 - 01/2020
2Cardiovascular Diseases (Cardiovascular Disease)
12/2020 - 08/2009
2Hypertriglyceridemia
12/2020 - 11/2004
2Neoplasms (Cancer)
01/2020 - 11/2017
2Glucose Intolerance
03/2016 - 01/2014
2Uremia
02/2015 - 01/2014
2Body Weight (Weight, Body)
01/2014 - 02/2012
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
12/2020

Drug/Important Bio-Agent (IBA)

8Glucose (Dextrose)FDA LinkGeneric
02/2018 - 01/2008
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2020 - 05/2009
6Proteins (Proteins, Gene)FDA Link
03/2022 - 12/2010
6SodiumIBA
01/2022 - 03/2004
6Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2020 - 07/2005
5NF-kappa B (NF-kB)IBA
12/2021 - 08/2009
5FructoseIBA
03/2016 - 11/2004
5Cell Adhesion MoleculesIBA
01/2013 - 08/2009
5CreatinineIBA
01/2011 - 03/2004
4oryeongsanIBA
01/2022 - 01/2014
4Atrial Natriuretic Factor (ANF)IBA
01/2022 - 01/2018
4NG-Nitroarginine Methyl Ester (L-NAME)IBA
01/2021 - 04/2002
4ApolipoproteinsIBA
01/2021 - 11/2014
4CholesterolIBA
12/2020 - 01/2012
4Biomarkers (Surrogate Marker)IBA
09/2020 - 02/2015
4Insulin (Novolin)FDA Link
03/2019 - 01/2014
4Heme Oxygenase-1IBA
01/2014 - 09/2005
4CytokinesIBA
04/2012 - 01/2007
4Aquaporin 2IBA
01/2012 - 08/2004
4Adenosine Triphosphatases (ATPase)IBA
01/2011 - 08/2004
3Puromycin AminonucleosideIBA
03/2022 - 01/2014
3ORALIT (ORS)IBA
01/2022 - 01/2014
3Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 01/2002
3Betulinic AcidIBA
12/2020 - 01/2010
3Triglycerides (Triacylglycerol)IBA
12/2020 - 01/2014
3Periodic AcidIBA
10/2020 - 01/2011
3CollagenIBA
09/2020 - 02/2015
3Connective Tissue Growth FactorIBA
09/2020 - 02/2015
3Blood Glucose (Blood Sugar)IBA
03/2019 - 01/2014
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
03/2019 - 02/2015
3Apolipoproteins E (ApoE)IBA
09/2018 - 11/2014
3Aquaporins (Water Channels)IBA
01/2014 - 01/2011
3Endothelin-1 (Endothelin 1)IBA
02/2012 - 08/2005
3Transcription Factors (Transcription Factor)IBA
08/2009 - 07/2005
3Methanol (Carbinol)IBA
01/2007 - 07/2005
2InflammasomesIBA
10/2021 - 09/2020
2Nitroarginine (NG Nitro L Arginine)IBA
01/2021 - 03/2004
2Toll-Like Receptor 4IBA
01/2021 - 10/2020
2LipidsIBA
01/2021 - 04/2017
2Protective AgentsIBA
01/2021 - 01/2016
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
11/2020 - 02/2012
2HMGB1 Protein (HMG1)IBA
10/2020 - 04/2017
2sauchinoneIBA
09/2020 - 01/2014
2Angiotensin IIIBA
09/2020 - 01/2018
2Cell Adhesion Molecule-1IBA
03/2019 - 02/2015
2si-wu-tangIBA
01/2018 - 01/2016
2AntioxidantsIBA
11/2017 - 08/2004
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2017 - 08/2004
2Therapeutic UsesIBA
04/2017 - 01/2012
2LipopolysaccharidesIBA
01/2017 - 09/2016
2C-Reactive ProteinIBA
03/2016 - 01/2015
2LDL Lipoproteins (beta Lipoproteins)IBA
02/2012 - 06/2010
2Arginine (L-Arginine)FDA Link
07/2005 - 04/2002
2Nitric Oxide Synthase (NO Synthase)IBA
03/2004 - 04/2002
1Messenger RNA (mRNA)IBA
03/2022
1securinineIBA
01/2021
1Mao-toIBA
01/2021
1mahuang-tangIBA
01/2021
1NucleotidesIBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
12/2020
1AnthracyclinesIBA
12/2020
1CalcineurinIBA
12/2020
1Brain Natriuretic Peptide (Natrecor)FDA Link
12/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2020
1Myosins (Myosin)IBA
12/2020
1Ventricular MyosinsIBA
12/2020
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2020
1Interleukin-6 (Interleukin 6)IBA
10/2020

Therapy/Procedure

4Therapeutics
02/2018 - 02/2015
2Traditional Medicine (Folk Remedies)
10/2020 - 01/2012
2East Asian Traditional Medicine (Oriental Medicine)
05/2017 - 01/2013
2Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2013 - 02/2012
1Surgical Instruments (Clip)
01/2021